Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04688502
Other study ID # 2431
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date June 11, 2022
Est. completion date February 15, 2023

Study information

Verified date May 2022
Source University of Saskatchewan
Contact Philip Chilibeck, Ph.D.
Phone 1-306-343-6577
Email phil.chilibeck@usask.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Face masks are important for prevention of transmission and contracting viruses such as COVID-19. Gymnasiums have been identified as being susceptible to virus transmission; therefore, wearing face masks during exercise is important during pandemics. This study will evaluate performance and physiological stress during high-intensity exercise while wearing a face mask during Crossfit exercise training.


Description:

Face masks are important for prevention of transmission and contracting viruses such as COVID-19. Gymnasiums have been identified as being susceptible to virus transmission; therefore, wearing face masks during exercise is important during pandemics. This study will evaluate performance and physiological stress during high-intensity exercise while wearing a face mask during Crossfit exercise training. Twenty-four men and women will be randomly assigned to perform exercise during Crossfit exercise while wearing or not wearing a surgical face mask in a cross-over study. Two types of exercise sessions will be assessed: A high intensity interval session and a continuous exercise session. There will therefore be four exercise sessions evaluated in our randomized cross-over design: 1) high intensity exercise while wearing a face mask; 2) high intensity exercise with no face mask; 3) continuous exercise while wearing a face mask; 4) continuous exercise with no face mask. Outcome variables to be assessed include exercise performance during the sessions (total repetitions for pull-ups, push-ups, and squats during continuous exercise and total repetitions for box jumps during high-intensity exercise). Heart rate, rating of perceived exertion, and dyspnea will also be assessed throughout the exercise sessions.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 24
Est. completion date February 15, 2023
Est. primary completion date January 28, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Experienced with CrossFit exercise training Exclusion Criteria: - Contra-indications to exercise as identified by a screening questionnaire (the "Get Active Questionnaire")

Study Design


Related Conditions & MeSH terms


Intervention

Other:
High intensity interval training
High intensity interval training: 6 sets x 8 bench press, 10 pull-ups, and maximal number of box jumps (each set lasting 60 sec, with 4 minutes rest between sets)
Continuous exercise training
5 pull-ups, 10 push-ups, and 15 body-weight squats, repeated for 30 minutes

Locations

Country Name City State
Canada University of Saskatchewan Saskatoon Saskatchewan

Sponsors (1)

Lead Sponsor Collaborator
University of Saskatchewan

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline in box jumps Number of box jump repetitions during high intensity exercise Up to 30 minutes
Primary Change from baseline in pull-up, push-up, and squat repetitions Number of repetitions performed for pull-ups, push-ups, and squats Up to 30 minutes
Secondary Change from baseline in rating of perceived exertion Rating of perceived exertion on a scale of 1-10 (Modified Borg Scale), a higher score indicates a greater perceived exertion Up to 30 minutes
Secondary Change from baseline in heart rate Heart rate (beats per minute) Up to 30 minutes
Secondary Change from baseline in dyspnea Dyspnea scale (0-10), a higher score indicates increased dyspnea Up to 30 minutes
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04688905 - Diagnosing Heart Failure With Preserved Ejection Fraction in Patients With Unexplained Dyspnea (Diagnose-HFpEF)
Completed NCT03679312 - The Effect of Inhaled Nitric Oxide on Dyspnea and Exercise Tolerance in COPD Phase 1/Phase 2
Recruiting NCT04868357 - Hypnosis for the Management of Anxiety and Breathlessness During a Pulmonary Rehabilitation Program N/A
Active, not recruiting NCT03604822 - Music Therapy Protocol to Support Bulbar and Respiratory Functions in ALS N/A
Completed NCT03626519 - Effects of Menthol on Dyspnoea in COPD Patients N/A
Completed NCT02638649 - Prehospital Use of Ultrasound in Undifferentiated Shortness of Breath
Terminated NCT02269761 - Chest Ultrasound of ER Patients With Cough or SOB
Completed NCT02248831 - Evaluation of Cardiopulmonary Diseases by Ultrasound N/A
Completed NCT02538770 - Rapid Viral Diagnostics in Adults to Reduce Antimicrobial Consumption and Duration of Hospitalization N/A
Recruiting NCT01655199 - Sensitivity of the Step Test to Detect Improvement in Dyspnea Following Bronchodilation in Patients With Chronic Obstructive Pulmonary Disease N/A
Active, not recruiting NCT01440764 - Aerosol Inhalation Treatment for Dyspnea Phase 1/Phase 2
Completed NCT01577407 - Non Opioid Treatment for Experimental Dyspnea Phase 3
Completed NCT01193998 - Impact of Validated Diagnostic Prediction Model of Acute Heart Failure in the Emergency Department N/A
Recruiting NCT04327882 - Point-of-care Ultrasound Interest in Dyspneic Emergency Department Patients: an Observational Bicentric Study
Completed NCT05029986 - Preventing Dyspnea During Speech in Older Speakers N/A
Not yet recruiting NCT04181359 - The Effect of Inhaled Nitric Oxide on Dyspnea and Exercise Tolerance in Interstitial Lung Disease. Phase 1/Phase 2
Recruiting NCT04615065 - Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine
Completed NCT04305639 - The Reliability and Validity of Turkish Version of ''The Dyspnea-ALS-Scale (DALS-15)"
Completed NCT04370990 - Automated Oxygen Administration -Rethinking Interventions Alleviating Dyspnea in Patients With COPD N/A
Completed NCT04375917 - Is Reduced Hypoxia Through a Robot Intervention, Associated With Sensory and Emotional Descriptions of Dyspnea, Anxiety, Depression, Symptom Burden and Anxiolytics N/A